GGrantScoutHQCreate alert

Curated topic

Health Grants for Small Businesses — Page 3

Health, biomedical and care-delivery opportunities that include small businesses in recorded eligibility.

369 current opportunities · showing 49–72

OPENHealth & Medical

Cooperative Research Agreements Related to the World Trade Center Health Program (U01)

Centers for Disease Control and Prevention - ERA

The National Institute for Occupational Safety and Health (NIOSH) supports research projects that address: (1) physical and mental health conditions related to the September 11, 2001, terrorist attacks; (2) diagnosing conditions for which there has been diagnostic uncertainty; and (3) treating condi

Deadline
Dec 9, 2026
Funding
Estimated total program funding: $49,500,000
Check fit and official source →
OPENSmall Business & Startups

Gambling harms research grants (Grant)

UK Government

Word limit: 550 In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for

Deadline
Dec 9, 2026
Funding
See official notice
Check fit and official source →
OPENSmall Business & Startups

BridgeAI Deployment Catalyst: AI for Decision Critical Systems

UK Government

Description Innovate UK, part of UK Research and Innovation (UKRI), will invest up to £5 million in BridgeAI Deployment Catalyst Phase 1. Across all three phases of the BridgeAI Deployment Catalyst programme, Innovate UK expects to make up to £52 million available. Funding for this phase and subsequent phases is subjec

Deadline
Dec 9, 2026
Funding
See official notice
Check fit and official source →
OPENSmall Business & Startups

BridgeAI Deployment Catalyst: AI for Assurance and Compliance

UK Government

Description Innovate UK, part of UK Research and Innovation (UKRI), will invest up to £5 million in BridgeAI Deployment Catalyst Phase 1. Across all three phases of the BridgeAI Deployment Catalyst programme, Innovate UK expects to make up to £52 million available. Funding for this phase and subsequent phases is subjec

Deadline
Dec 9, 2026
Funding
See official notice
Check fit and official source →
OPENSmall Business & Startups

BridgeAI Deployment Catalyst: AI for Operational Systems

UK Government

Description Innovate UK, part of UK Research and Innovation (UKRI), will invest up to £5 million in BridgeAI Deployment Catalyst Phase 1. Across all three phases of the BridgeAI Deployment Catalyst programme, Innovate UK expects to make up to £52 million available. Funding for this phase and subsequent phases is subjec

Deadline
Dec 9, 2026
Funding
See official notice
Check fit and official source →
OPENSmall Business & Startups

Manufacturing Scale-up Network Plus (Grant)

UK Government

Word limit: 550 In plain English, provide a summary we can use to identify the most suitable experts to assess your application. We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for

Deadline
Dec 10, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)

National Institutes of Health

The National Human Genome Research Institute (NHGRI) is publishing a Notice of Funding Opportunity (NOFO) to solicit applications for the Impact of Genomic Variation on Function (IGVF) Data and Coordinating Center (DACC). The DACC will serve as the coordinating center for the IGVF Consortium and wil

Deadline
Dec 15, 2026
Funding
Estimated total program funding: $6,000,000
Check fit and official source →
OPENHealth & Medical

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to characterize genomic variation to assess the impact of individual variants on genome function. This will be accomplished by systematically perturbing variants or elements using one or more high-throughput methods;

Deadline
Dec 15, 2026
Funding
Estimated total program funding: $15,000,000
Check fit and official source →
OPENHealth & Medical

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to develop, apply, and test predictive models and perform integrative analyses to determine the impact of genomic variation on genome function. Centers funded through this initiative will become a part of the Impact

Deadline
Dec 15, 2026
Funding
Estimated total program funding: $5,000,000
Check fit and official source →
OPENClimate & Environment

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to study the effects of genetic or environmental interactions on genomic variant impact. To accomplish this, interaction centers will first propose a research framework to investigate whether interactions with effect

Deadline
Dec 15, 2026
Funding
Estimated total program funding: $10,000,000
Check fit and official source →
OPENSmall Business & Startups

Trauma Recovery Center Grant Fiscal Year 27/28

Victim Compensation Board

The Trauma Recovery Center Grant funds centers throughout California that assist victims of violent crime. These centers provide wrap-around services and assist victims who are typically unserved and underserved communities.

Deadline
Dec 15, 2026
Funding
Dependant on number of submissions received, application process, etc.
Check fit and official source →
OPENHealth & Medical

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

National Institutes of Health

The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations t

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in unders

Deadline
Jan 8, 2027
Funding
Estimated total program funding: $500,000
Check fit and official source →
OPENHealth & Medical

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol consumption, developing and/or evaluating alcohol poli

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

National Institutes of Health

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research missi

Deadline
Jan 8, 2027
Funding
Estimated total program funding: $499,999
Check fit and official source →
OPENHealth & Medical

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

National Institutes of Health

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, he

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENEducation

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary across the natural and s

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists wh

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

National Institutes of Health

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists wh

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. NLM seeks applications that further the science of personal health inform

Deadline
Jan 8, 2027
Funding
Up to $250,000
Check fit and official source →
OPENHealth & Medical

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) for R34 planning grant applications focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenat

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

National Institutes of Health

This NOFO is a call to action in response to the mental health crisis in the United States. We seek applications that will study methods to increase access to evidence-based interventions and services for youth mental health, including those living in rural areas, inner cities, and other under-resou

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health

The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activit

Deadline
Jan 8, 2027
Funding
See official notice
Check fit and official source →

Strong fit signals

  • The health need is evidenced
  • Regulatory milestones are understood
  • The work fits the program stage

Requirements to verify

  • Clinical and human-subject requirements
  • Allowable product-development costs

How to use this shortlist

Open the official notice for each candidate and build a simple go/no-go table covering legal applicant type, geography, project purpose, award range, match, registrations and submission time zone. Eliminate any program that fails a mandatory condition before spending time on narrative drafting.

Frequently asked questions

Who should use this health grants for small businesses page?

Health ventures and small biomedical companies. Treat the directory match as a discovery signal and confirm the controlling eligibility language on the funder's notice.

How are opportunities selected?

The page applies a fixed combination of structured applicant, focus, source, award or deadline signals to current directory records. It does not broaden the result with unrelated keywords.

Does a listing mean my organization is eligible?

No. A match helps build a shortlist; the official notice, application package and funder guidance control eligibility and allowable costs.